Literature DB >> 11181809

Collecting duct is a site of sodium retention in PAN nephrosis: a rationale for amiloride therapy.

Georges Deschênes1,2, Monika Wittner2, Antonio DI Stefano2, Sylvie Jounier2, Alain Doucet2.   

Abstract

Micropuncture studies of the distal nephron and measurements of Na,K-ATPase activity in microdissected collecting tubules have suggested that renal retention of sodium in puromycin aminonucleoside (PAN) nephrotic rats originates in the collecting duct. The present study demonstrated this hypothesis by in vitro microperfusion and showed that amiloride was able to restore sodium balance. Indeed, isolated perfused cortical collecting ducts from PAN-treated rats exhibited an abnormally high transepithelial sodium reabsorption that was abolished by amiloride, and in vivo administration of amiloride fully prevented decreased urinary sodium excretion and positive sodium balance in nephrotic rats. As expected from the aldosterone independence of Na(+) retention in PAN nephrotic rats, blockade of aldosterone receptor by potassium canrenoate did not alter urinary Na(+) excretion, Na(+) balance, or ascites formation in PAN nephrotic rats.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181809     DOI: 10.1681/ASN.V123598

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  27 in total

1.  Decreased renal corin expression contributes to sodium retention in proteinuric kidney diseases.

Authors:  Danny Polzin; Henriette J Kaminski; Christian Kastner; Wei Wang; Stephanie Krämer; Stepan Gambaryan; Michael Russwurm; Harm Peters; Qingyu Wu; Alain Vandewalle; Sebastian Bachmann; Franziska Theilig
Journal:  Kidney Int       Date:  2010-07-07       Impact factor: 10.612

Review 2.  Regulated sodium transport in the renal connecting tubule (CNT) via the epithelial sodium channel (ENaC).

Authors:  Johannes Loffing; Christoph Korbmacher
Journal:  Pflugers Arch       Date:  2009-03-11       Impact factor: 3.657

Review 3.  Sodium retention and volume expansion in nephrotic syndrome: implications for hypertension.

Authors:  Evan C Ray; Helbert Rondon-Berrios; Cary R Boyd; Thomas R Kleyman
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

Review 4.  Renal dopaminergic system: Pathophysiological implications and clinical perspectives.

Authors:  Marcelo Roberto Choi; Nicolás Martín Kouyoumdzian; Natalia Lucía Rukavina Mikusic; María Cecilia Kravetz; María Inés Rosón; Martín Rodríguez Fermepin; Belisario Enrique Fernández
Journal:  World J Nephrol       Date:  2015-05-06

Review 5.  Epithelial Na+ Channel Regulation by Extracellular and Intracellular Factors.

Authors:  Thomas R Kleyman; Ossama B Kashlan; Rebecca P Hughey
Journal:  Annu Rev Physiol       Date:  2017-11-09       Impact factor: 19.318

6.  Inhibition of K+ secretion in the distal nephron in nephrotic syndrome: possible role of albuminuria.

Authors:  Marc Fila; Gaëlle Brideau; Luciana Morla; Lydie Cheval; Georges Deschênes; Alain Doucet
Journal:  J Physiol       Date:  2011-05-23       Impact factor: 5.182

7.  Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin.

Authors:  Bernhard N Bohnert; Ferruh Artunc
Journal:  J Vis Exp       Date:  2018-05-06       Impact factor: 1.355

8.  Plasmin in nephrotic urine activates the epithelial sodium channel.

Authors:  Per Svenningsen; Claus Bistrup; Ulla G Friis; Marko Bertog; Silke Haerteis; Bettina Krueger; Jane Stubbe; Ole Nørregaard Jensen; Helle C Thiesson; Torben R Uhrenholt; Bente Jespersen; Boye L Jensen; Christoph Korbmacher; Ole Skøtt
Journal:  J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 10.121

Review 9.  Urinary serine proteases and activation of ENaC in kidney--implications for physiological renal salt handling and hypertensive disorders with albuminuria.

Authors:  Per Svenningsen; Henrik Andersen; Lise H Nielsen; Boye L Jensen
Journal:  Pflugers Arch       Date:  2014-12-09       Impact factor: 3.657

10.  Over-expression of adenosine deaminase in mouse podocytes does not reverse puromycin aminonucleoside resistance.

Authors:  Gaëlle Brideau; Alain Doucet
Journal:  BMC Nephrol       Date:  2010-07-22       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.